Explorez tous les épisodes du podcast She Leads Biotech

Amy Walker didn't set out to become a CEO.

In this episode of She Leads Biotech, I’m joined by Amy, CEO of 4basebio, to explore how a career that began in science evolved into leading a growing biotech company.

We talk about growing alongside a business, stepping beyond your original expertise, building the right leadership team and culture, and the technology changing the future of DNA manufacturing and advanced therapies.

It’s a conversation about science, leadership, career progression and being willing to take opportunities you never originally planned for.

#SheLeadsBiotech #Biotech #WomenInBiotech #BiotechLeadership #DNAManufacturing #AdvancedTherapies

What happens when you reach one of the most senior positions in global drug discovery — and decide the next step is to leave the security of Big Pharma behind?

In this episode of She Leads Biotech, I’m joined by Karin Conde-Knape, PhD, Chief Science Officer at Valo Health, whose international career has taken her through leadership roles at Roche, Johnson & Johnson and Novo Nordisk.

We talk about why Karin believes better drug discovery needs to start with human data, how asking the right questions earlier can prevent years of time and investment being committed to the wrong path, and where data, experience and intuition belong in scientific decision-making.

We also explore Karin’s decision to move from Big Pharma to biotech — what she describes as an “easier choice, not a comfortable choice” — and why impact, people and purpose became increasingly important at this stage of her career.

Our conversation moves beyond the science into leadership: creating psychological safety, challenging the thought process rather than the individual, developing resilient future leaders, embracing AI and new technologies, and building teams that genuinely want to follow you.

A fascinating conversation about drug discovery, human data, innovation, career courage and the leadership required to turn better questions into better science.

What does it really take to lead a biotech company when the science is complex, the stakes are high and the answers aren’t always obvious?

In this episode of She Leads Biotech, I’m joined by Iris Grossman, PhD, CEO of Zelig Therapeutics, for a candid conversation about the realities of biotech leadership and her journey from scientist to CEO.

In When Leadership Gets Real: Ego, Accountability & the Decisions That Shape Biotech Companies, we talk about what happens when leadership moves beyond the title and you become the person ultimately accountable for the decisions.

We explore why great leaders surround themselves with people who will challenge them, how founders and leadership teams need to evolve as companies grow, why strategy starts with knowing your values, and what Iris has learned about hiring beyond technical capability.

Iris also talks openly about making decisions without perfect information, handling difficult performance conversations, keeping ego out of leadership — and why patient impact remains her North Star.

Chapters

00:00 Introduction
03:17 A Patient-Centric North Star
05:46 The Scientist Inside the CEO
07:04 Turning Science into Patient Impact
10:14 The Reality of CEO Accountability
13:30 When Founders and Companies Need to Evolve
14:39 Why Independent Boards Matter
15:43 Strategy Starts with Values
17:17 Why Zelig Became a Call to Action
20:01 Making Decisions Through Uncertainty
23:28 Why Personality Matters in Hiring
26:24 The Difficult People Decisions Leaders Must Make
30:09 Why Biotech Is Ultimately About People

🎧 Follow She Leads Biotech for more conversations with the people building, leading and shaping biotech.

#SheLeadsBiotech #BiotechLeadership #Biotech #LifeSciences #WomenInBiotech #Leadership

What happens when the career plan you thought you had suddenly changes?

In this episode of She Leads Biotech, I’m joined once again by Priya Baraniak, PhD, Chief Commercial & Development Officer at Pluristyx, who returns to the podcast after first joining me back in Season 1.

In When the Plan Changes: Resilience, Reinvention & Finding Your Way in Biotech, we talk candidly about unexpected career change, resilience and what happens when you have to let go of the plan and find a different way forward.

Priya shares what she learned following a professional setback, why personal branding and authentic relationships became so important, and how her own career has evolved from scientist to commercial biotech leader.

We also explore the realities of biotech fundraising, what investors look for in leadership teams, the potential of iPSC technology and cell and gene therapy — and why, despite the challenges facing our industry, Priya remains incredibly excited about what the science can achieve for patients.

Above all, it’s a conversation about becoming more comfortable with uncertainty, focusing on what you can control and continuing to do the next right thing.

Chapters

01:23 When Everything Changes
05:25 Losing a Role: The First 72 Hours
10:05 Personal Branding & Getting Comfortable Being Visible
14:50 The Promise of iPSCs
18:00 From Scientist to Commercial Leader
21:31 What Fundraising Really Looks Like Today
23:29 Changing the Conversation About Inclusion
28:28 Why Cell & Gene Therapy Still Excites Her
31:28 What 13-Year-Old Priya Would Think Today
35:27 Just Keep Doing the Next Right Thing
37:02 Tough Times Didn't Break Us, They Made Us

🎧 Follow She Leads Biotech for more conversations with the people building, leading and shaping biotech.

#SheLeadsBiotech #Biotech #BiotechLeadership #CellAndGeneTherapy #WomenInBiotech #LifeSciences #BiotechCareers

Reimagining Rare Disease Drug Development with Nerissa Kreher

In this episode of She Leads Biotech, I’m joined by Nerissa Kreher, Chief Medical Officer of Alltrna, for a conversation about rare disease innovation, precision medicine, and the future of drug development.

With more than 20 years of experience in rare diseases, Nerissa shares her journey from pediatric endocrinologist to biotech executive and explains how Alltrna is taking a novel approach to treating genetic diseases through mutation-defined therapies.

A fascinating discussion about science, innovation, leadership, and hope for families living with rare diseases.

Chapters

00:00 Introduction
02:00 From Medicine to Biotech
05:00 Falling in Love with Rare Disease Research
08:00 Understanding Rare Disease Communities
12:00 The Challenge of Clinical Trials in Rare Diseases
16:00 Mutation-Defined Therapies Explained
21:00 How Alltrna Is Rethinking Drug Development
26:00 Regulatory & Clinical Development Challenges
31:00 Public vs Private Company Leadership
35:00 What Makes a Great Biotech Executive
39:00 Leadership, Mentorship & Authenticity
43:00 The Role of Patients in Drug Development
47:00 The Future of Rare Disease Innovation
51:00 Bringing Hope to Patients & Families

#SheLeadsBiotech #RareDisease #PrecisionMedicine #GeneTherapy #BiotechLeadership #WomenInBiotech #CNAUSAExecutiveSearch

Leading with Purpose in Rare Disease with Sarah DiSalvatore

In this episode of She Leads Biotech, I’m joined by Sarah DiSalvatore, Fractional SVP of Clinical Operations & Biotech Executive, for a conversation about leadership, rare disease, and the realities of bringing innovative therapies to patients.

Sarah shares her journey from bench research to executive leadership, why quality and compliance are fundamental to successful clinical development, and how fractional leadership is helping early-stage biotech companies build smarter and more efficiently.

We also discuss the deeply personal experience of becoming a rare disease parent, and how that has transformed the way Sarah approaches patient advocacy, programme development, and the importance of building centres of excellence for underserved communities.

A thoughtful conversation about resilience, strategy, and keeping patients at the centre of every decision.

Chapters

00:00 Introduction
02:00 A Childhood Dream of Medicine
06:00 From Bench Research to Clinical Operations
11:00 Why Quality and Compliance Matter
16:00 Growing into Leadership
20:00 The Rise of Fractional Executives
25:00 Becoming a Rare Disease Parent
30:00 How Personal Experience Changed Clinical Development
34:00 Building Centres of Excellence for Rare Diseases
38:00 The Future of Clinical Operations
42:00 Advice for Parents, Caregivers & Leaders

#SheLeadsBiotech #RareDisease #ClinicalOperations #BiotechLeadership #GeneTherapy #WomenInBiotech #CNAUSAExecutiveSearch

Beyond Burnout: Rethinking Leadership and Identity with Melody Keel

In this episode of She Leads Biotech, I’m joined by Melody Keel, CEO of The Research Associate Group, for a candid conversation about clinical operations, leadership, burnout, and building a life beyond your job title.

With more than 20 years of experience in clinical operations, Melody shares what she’s learned about leading teams, navigating high-pressure environments, and why empathy is one of the most powerful tools a leader can have.

We also discuss the changing biotech job market, the importance of personal branding, and why your career should never become your entire identity.

Whether you work in clinical operations or any area of life sciences, this episode is packed with practical insights and honest reflections.

Chapters

00:00 Introduction
02:10 Falling into Clinical Operations
05:00 Why Great Leaders Put People First
09:30 The Reality of Burnout in ClinOps
14:00 Sponsor vs CRO Life
17:20 A Personal Wake-Up Call
20:00 Building a Life Beyond Work
23:00 The Future of Careers in Biotech
27:00 Why Your Personal Brand Matters
30:00 Supporting Women Through Career Change
33:00 Finding Your Purpose Beyond Your Job

#SheLeadsBiotech #ClinicalOperations #Leadership #WomenInBiotech #CareerGrowth #LifeSciences #CNAUSAExecutiveSearch

Building Your Own Table with Jennifer Daily

In this episode of She Leads Biotech, I’m joined by Jennifer Daily, neuroscientist, biotech executive, and founder, for a conversation about leadership, drug development, and the journey from employee to entrepreneur.

Jennifer shares how working across clinical development, regulatory affairs, manufacturing, and preclinical research gave her a unique perspective on what it really takes to move therapies from concept to patient.

We also discuss the realities of gene therapy, why execution is often more important than great science alone, the power of building a strong network, and what inspired her to launch her own company in the neuroscience space.

A thoughtful conversation about leadership, risk-taking, and creating opportunities instead of waiting for them.

Chapters

00:00 Introduction
02:30 Discovering Science & Neuroscience
05:00 Moving from Academia to Industry
08:00 What Industry Looks for in Scientists
10:00 Seeing the Full Drug Development Picture
13:00 Why Great Science Isn't Enough
16:00 Funding Plans, Not Hope
19:00 From Executive to Founder
22:00 Building a Company in Neuroscience
25:00 Creating a Culture Where Every Voice Matters
28:00 Risk, Decision-Making & Leadership
31:00 The Future of Gene Therapy
34:00 Career Advice, Networking & Growth

#SheLeadsBiotech #WomenInBiotech #BiotechLeadership #GeneTherapy #Neuroscience #FemaleFounder #CNAUSAExecutiveSearch

Rethinking IVF with Ivana Muncie-Vasic

In this episode of She Leads Biotech, we’re joined by Ivana Muncie-Vasic, CEO & Founder of Vitra Labs, for a conversation about fertility innovation, bioengineering, and building a biotech company from the ground up.

Ivana shares how her work in stem cell biology led to the development of hormone-free IVF technology designed to reduce the physical and financial burden of fertility treatment for patients.

We also talk about the realities of becoming a first-time founder, navigating imposter syndrome, building resilience as a CEO, and how becoming a new mother has deepened her connection to the mission behind Vitra Labs.

Chapters

00:00 Introduction
02:00 Finding Bioengineering & Stem Cell Research
07:00 Why Patient Impact Became the Focus
10:00 From Academic Research to Founding Vitra Labs
14:00 The Science Behind Hormone-Free IVF
19:00 Why Traditional IVF Is So Difficult on Women
23:00 Becoming a First-Time CEO
27:00 Panic Attacks, Pressure & Founder Reality
31:00 The Importance of Support & Coaching
34:00 Becoming a Mother While Building a Startup
37:00 Advice for Future Founders

#SheLeadsBiotech #WomensHealth #FertilityInnovation #IVF #WomenInBiotech #CNAUSAExecutiveSearch

Changing the Conversation Around Women’s Health with Saundra Pelletier & Mitch Rosen

In this episode of She Leads Biotech, we’re joined by Saundra Pelletier and Mitch Rosen from Evofem Biosciences for a candid conversation about women’s health, education, intimacy, and the importance of normalizing these discussions.

We explore why women deserve more options, why men need to be part of the conversation too, and how a new generation is changing the way people think about sexual health and communication.

From access and advocacy to stigma, healthcare gaps, and the power of education, this episode is honest, insightful, and surprisingly fun.

Chapters

00:00 Introduction
03:00 Evofem, Phexxi & Women’s Choice
07:00 The “Say Vagina” Campaign
12:00 Why Men Need to Join the Conversation
16:00 How Mitch Found Women’s Health
21:00 What’s Changing in Women’s Healthcare
26:00 Shared Responsibility & Communication
31:00 Generational Shifts Around Intimacy
35:00 Myths & Misconceptions in Women’s Health
40:00 AI, Access & The Future of Care
45:00 What Real Progress Looks Like
49:00 Final Advice & Takeaways

#SheLeadsBiotech #WomensHealth #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch

Trusting Your Judgement in Biotech with Anna Polak-Andersen

In this episode of She Leads Biotech, we’re joined by Anna Polak-Andersen, CEO of AnRes Clinical, for a thoughtful conversation about clinical development, leadership, and navigating the biotech industry across Europe.

Anna shares her journey from studying pharmacy in Poland to leading a clinical development consultancy supporting biotech companies and rare disease programs across the industry.

We talk about the realities of clinical research, the importance of strategic thinking in development, the current European biotech landscape, and why learning to trust your own judgement is one of the most important leadership lessons of all.

Chapters

00:00 Introduction
03:00 Why Anna Chose Clinical Development
08:00 Early Career at Pfizer
11:00 Staying Connected to Patient Impact
15:00 What Makes AnRes Clinical Different
20:00 Choosing the Right Clients & Partnerships
24:00 European Biotech & Funding Challenges
28:00 Women in Leadership & Self-Doubt
32:00 Trusting Your Own Judgement
35:00 Advice for the Next Generation

#SheLeadsBiotech #ClinicalDevelopment #WomenInBiotech #BiotechLeadership #CNAUSAExecutiveSearch

Building a biotech company takes more than science.

In this episode of She Leads Biotech, Dr. Stella Vnook, CEO of Aviva Ventures, shares her journey from arriving in the US with nothing to leading multiple biotech ventures and supporting the next generation of founders.

We explore the realities of building in biotech, from self-doubt and uncertainty to navigating the business side of science, and why so many great ideas never get started.

A practical and honest conversation about resilience, leadership, and what it really takes to turn science into impact.

Chapters

00:00 Introduction
01:30 Stella’s Early Journey
05:00 Building a Career in Life Sciences
09:00 Self-Doubt and Leadership
13:00 From Pharma to Entrepreneurship
18:00 Starting Without Knowing How
23:00 Common Mistakes Founders Make
27:00 Building Multiple Companies
32:00 The Story Behind Caerra
36:00 Aviva Ventures and Supporting Founders
40:00 Advice for Early-Stage Founders
44:00 What Success Looks Like

#SheLeadsBiotech #WomenInBiotech #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch

Solving More Than Science with Adrienne Mendoza

Cell and gene therapy is advancing rapidly, but science alone isn’t enough.

In this episode of She Leads Biotech, Adrienne Mendoza, Chief Operating Officer of BBG Advanced Therapies, shares what’s really needed to move the field forward, from improving access and infrastructure to rethinking how these therapies reach patients.

We also explore her journey over the past year, building a stronger presence in the industry, translating complex science for broader audiences, and the realities of leading through a challenging and evolving market.

A practical and honest look at where the field is today, and what it will take to get to the next stage.

Chapters

00:00 Introduction
02:00 Stepping into a New Role at BBG Advanced Therapies
05:00 How the Role of a COO Evolves
08:30 Building Presence and Community in CGT
12:00 Making Complex Science Understandable
16:00 The Mobile Leukapheresis Bus
21:00 Access Challenges in Cell & Gene Therapy
27:00 What Needs to Change in the System
33:00 Industry Challenges and Optimism
38:00 What the Next 5 Years Could Look Like
41:00 Life Outside of Biotech

#SheLeadsBiotech #CellAndGeneTherapy #BiotechLeadership #LifeSciences #CNAUSAExecutiveSearch

Rethinking Eye Care: From NanoDropper to Mu Medical

What started as a student project has turned into a company reshaping how eye care is delivered.

In this episode of She Leads Biotech, we’re joined by Allisa Song, CEO of Mu Medical, and Mackenzie Andrews, CCO, to talk about the journey from an idea sparked in a research lab to a product now used across thousands of clinics.

They share how a simple question, why are eye drops too big, led to a solution that improves patient outcomes, reduces waste, and is now evolving into something much bigger.

We also get into co-founder dynamics, building in a complex healthcare system, and the reality of being young female leaders in a traditionally male-dominated space.

A practical, honest conversation about building, scaling, and challenging assumptions in healthcare.

Chapters

00:00 Introduction
01:30 Meet Allisa & Mackenzie
04:00 From Research Lab to Startup Idea
08:30 The Eye Drop Problem Explained
13:00 Building NanoDropper
18:30 When It Became a Real Business
22:00 Product Demo & Clinical Impact
26:00 Go-to-Market Strategy
30:00 Working with Insurers, Clinics & Pharma
34:00 Evolving into Mu Medical
38:00 Co-Founder Dynamics & Trust
42:00 Being Women in a Male-Dominated Industry
47:00 Advice for Founders
51:00 What’s Next for Mu Medical

Listen / Watch:
Spotify | YouTube

#SheLeadsBiotech #MedTech #HealthcareInnovation #WomenInBiotech #CNAUSAExecutiveSearch

Finding Your Path in Biotech with Connie Chang

Careers in biotech rarely follow a straight line.

In this episode of She Leads Biotech, we speak with Connie Chang, Chief Operating Officer of ONL Therapeutics, about a career that has spanned big pharma, academia, and emerging biotech, and how each step has shaped the way she leads today.

Connie shares how early career decisions don’t always define where you end up, and why sometimes “the career picks you” rather than the other way around.

We explore the reality of moving between very different environments, from highly structured global organizations to small, fast-moving biotech companies, and what it really takes to adapt and succeed in both.

This conversation also highlights the importance of community throughout your career, the role academia plays in driving innovation, and the personal side of leadership, including navigating family decisions, career risks, and the pressure many women face as they progress into senior roles.

A thoughtful and honest discussion on building a career, leading with intention, and continuing to grow, even when you’re already at the top.

Chapters

00:00 Introduction
01:30 How Connie Found Biotech
04:00 Harvard, Community, and Early Influences
06:30 Big Pharma, Academia, and Connecting the Dots
10:00 Taking Career Risks and Moving to Michigan
14:30 ONL Therapeutics and the Mission Behind the Science
18:00 What a COO Role Really Looks Like in Biotech
20:30 Building Teams in Small Biotech
23:00 Leadership Style and Creating Trust
26:00 Adapting Across Cultures and Environments
29:00 Women in Leadership and Career Progression
32:00 Being the Only One at the Table
35:00 Self-Doubt, Growth, and Resilience
37:30 What’s Next for ONL and Connie

#SheLeadsBiotech #BiotechLeadership #WomenInBiotech #LifeSciences #CNAUSAExecutiveSearch

Leading Women’s Health Innovation: From Clinical Practice to CEO with Mandy Pulliam

In this episode of She Leads Biotech, I’m joined by Samantha (Mandy) Pulliam, CEO and Chief Medical Officer at Axena Health, for a conversation that highlights what it really takes to lead in women’s health.

Mandy’s journey is a unique one. She started her career as a practicing physician before stepping into the biotech and medtech space, bringing with her a deep understanding of patient care that continues to shape how she leads today.

What stood out to me in this conversation is how intentional she has been about bridging clinical insight with innovation. At Axena Health, she’s focused on addressing conditions that have historically been under-discussed and underserved, particularly in pelvic health.

We talk about the realities of building and leading in women’s health, where the need is significant, but awareness, funding, and attention have often lagged behind.

Mandy shares how she approaches leadership as both a clinician and a CEO, how she thinks about patient impact alongside commercial success, and why creating solutions in this space requires both persistence and a willingness to challenge long-standing assumptions.

This is a conversation about leadership, purpose, and the responsibility that comes with developing products that directly impact patients’ quality of life.

And a reminder that innovation in healthcare isn’t just about new technology, it’s about truly understanding the people you’re trying to help.

📌 Chapters

00:00 Introduction
01:48 Mandy’s journey from physician to CEO
03:52 Moving from clinical practice into industry
05:41 Why women’s health remains underserved
07:32 The mission behind Axena Health
09:18 Addressing pelvic health challenges
11:05 Bridging patient care and innovation
13:12 Leadership as both a clinician and executive
15:20 Navigating funding and awareness gaps
17:08 Building solutions that truly serve patients
19:06 Commercial strategy in women’s health
21:14 Lessons learned stepping into the CEO role
23:02 Advice for women entering biotech leadership
24:40 Balancing purpose with business outcomes
26:18 The future of women’s health innovation

🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.

Subscribe for more conversations with biotech leaders, founders, and innovators.

#SheLeadsBiotech #WomensHealth #BiotechLeadership #LifeSciences #MedTech #WomenInBiotech #HealthcareInnovation #CNAUSAExecutiveSearch

Rethinking Rare Disease: A New Model for Ultra-Rare Therapies with Beth White

In this episode of She Leads Biotech, I’m joined by Elizabeth (Beth) White, COO and Co-Founder of Orphan Therapeutics Accelerator, for a conversation that really stayed with me.

Beth has spent her career at the intersection of science, strategy, and commercialization, and today she’s focused on one of the biggest challenges in our industry: how do we bring therapies to patients with ultra-rare diseases when the traditional biotech model simply doesn’t support them?

As Beth explains, the science has moved forward, especially in gene and cell therapies, but the business model hasn’t kept up. And that’s leaving too many promising therapies sitting on the shelf, never reaching the patients who need them.

What she and her team are building with the Orphan Therapeutics Accelerator is a completely different approach. A nonprofit biotech model designed to rethink how therapies are funded, developed, and ultimately delivered to patients.

We talk about what that actually looks like in practice, from new ways of funding and partnering, to the creation of the CGT Exchange, a marketplace designed to unlock shelved assets and give them a path forward.

This is one of those conversations that really challenges how you think about drug development, investment, and impact.

And a reminder that behind every “ultra-rare” disease are real patients, real families, and a very real urgency to find solutions.

📌 Chapters

00:00 Introduction
01:52 Why ultra-rare diseases remain underserved
03:44 What the Orphan Therapeutics Accelerator is
05:00 Building a completely new development model
06:32 How the nonprofit structure works in practice
08:39 Creating awareness and industry engagement
10:34 Major partnerships and recent momentum
11:39 What the CGT Exchange is and why it matters
13:26 Can this model work at scale?
15:08 Beth’s journey into rare disease and gene therapy
17:01 Bridging science and business
19:18 Leadership across pharma, biotech, and nonprofit
21:19 Big pharma vs biotech mindset
23:09 Leading with limited resources
24:21 Advice for women in biotech
25:37 Risk-taking and career decisions
26:17 The future of rare disease development
28:40 The role of AI in accelerating progress

🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.

Subscribe for more conversations with biotech leaders, founders, and innovators.

#SheLeadsBiotech #BethWhite #RareDisease #GeneTherapy #BiotechInnovation #WomenInBiotech #LifeSciences #CNAUSAExecutiveSearch

From Data to Discovery: Accelerating Drug Development with Samantha Dale Strasser

In this episode of She Leads Biotech, I sit down with Samantha Dale Strasser, VP of Strategy at Cellular Intelligence, for a fascinating conversation at the intersection of biology, computation, and patient impact.

Samantha’s journey spans biomedical engineering, applied mathematics, physics, and a PhD at MIT, but what truly shaped her path was something deeply personal. Her father’s diagnosis with frontotemporal dementia brought into sharp focus just how far we still have to go in treating complex diseases, and sparked a determination to accelerate how we move new technologies from the lab into the hands of patients.

We talk about her transition from academia into entrepreneurship, co-founding PepperBio, and now her work at Cellular Intelligence, where she is helping to build a platform that is fundamentally changing how we ask and answer biological questions.

What stood out to me in this conversation is just how much the pace of science is shifting. Questions that once took years to answer can now be explored in months, opening up entirely new possibilities for drug discovery and treatment.

We also dive into leadership, resilience, and what it really takes to build something from scratch in uncertain times.

📌 Chapters

00:00 Introduction
00:10 Samantha’s background and academic journey
02:10 Early interest in biology and computation
04:15 A personal turning point: her father’s diagnosis
05:32 Founding PepperBio and early entrepreneurship
06:35 What Cellular Intelligence is building
09:39 The role of AI and large-scale data in biology
10:43 How speed is transforming research timelines
11:41 Building a tech bio company
13:26 Leadership across different stages of her career
15:21 Motivating and growing scientific teams
16:44 Transitioning from operator to leader
18:29 The leadership training gap in life sciences
20:34 Resilience and building a company during COVID
23:44 Advice for scientists interested in entrepreneurship
26:19 What the future holds for Samantha and the field
28:00 A personal mission and long-term vision

🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.

Subscribe for more conversations with biotech leaders, founders, and innovators.

#SheLeadsBiotech #SamanthaDaleStrasser #CellularIntelligence #BiotechInnovation #DrugDiscovery #WomenInBiotech #LifeSciences #CNAUSAExecutiveSearch

In this episode of She Leads Biotech, Sharron Cox speaks with Joanna Ghayad, Founder & CEO of Joanna Ghayad Coaching, about leadership, influence, and the transition many scientists struggle to make as their careers grow.

Joanna’s career has taken her from working as an oncology pharmacist supporting cancer patients at the bedside, to roles in biotech and big pharma, and ultimately to launching her own leadership coaching practice focused on developing the next generation of leaders in life sciences.

After more than 15 years working across healthcare, biotech, and large pharmaceutical organizations, Joanna began to notice a consistent gap. Scientists are trained extensively in technical expertise, but very rarely taught how to lead teams, influence decisions, and communicate science in a way that drives business and patient impact.

In this conversation we explore the shift from technical expert to strategic leader, why scientists often get “boxed in,” and how professionals in life sciences can take ownership of their careers rather than waiting for someone else to define the next step.

Joanna also shares practical advice for scientists who want to grow their influence, build visibility within their organizations, and develop the leadership skills needed to move into executive roles.

If you're working in biotech, pharma, or the broader life sciences ecosystem and thinking about your next step, this is a conversation worth listening to.

Connect with Joanna Ghayad
LinkedIn: Joanna Ghayad
YouTube: The Revolutionary Stemmist

Joanna has also generously offered listeners a complimentary 20-minute coaching session, available through the link below: https://joannaghayadcoaching.com/conference/form

Chapters

00:00 Introduction
01:34 Joanna’s journey into pharmacy and oncology
03:33 Exploring career paths during pharmacy school
05:08 Transitioning from healthcare into biotech and pharma
09:08 Discovering the leadership gap in life sciences
10:30 Creating leadership training inside big pharma
13:38 Why scientists struggle with leadership and influence
16:08 The myth that scientists aren’t creative
20:40 Launching Joanna Ghayad Coaching
23:35 Moving from operator to leader
26:13 How coaching helps scientists advance their careers
28:20 Advice for scientists who want to grow into leadership
32:03 Navigating power dynamics in organizations
35:11 Authentic leadership and building respect
37:46 How to connect with Joanna

Megan McGill | Leadership, Credibility & Persistence in Biotech

CEO, Brenig Therapeutics

What does it really take to build credibility as a leader in biotech?

In this episode of She Leads Biotech, I sit down with Megan McGill, CEO of Brenig Therapeutics, to talk about leadership, persistence, and the realities women still face when building careers in the life sciences industry.

Megan shares her journey into biotech leadership and what it takes to step into the CEO role in a competitive and evolving sector.

One part of our conversation that really stood out was Megan’s honesty about something many women quietly experience: sometimes you have to outperform everyone else just to be taken seriously.

We talk about the importance of credentials, preparation, and resilience, and why continuing to push forward matters, even when the room isn’t designed with you in mind.

This conversation is an honest look at leadership, credibility, and the persistence required to succeed in biotech.

Chapters:

00:00 Introduction
01:45 Megan’s career journey into biotech
07:30 Moving into leadership roles
13:10 The reality of credibility and gender bias
18:20 Why credentials matter in leadership
24:15 Advice for women building careers in biotech
29:40 Leadership lessons as CEO of Brenig Therapeutics
34:30 Final advice for the next generation

🎙️ She Leads Biotech celebrates the journeys of women shaping the future of life sciences.

Subscribe for more conversations with biotech leaders, founders, and innovators.

#SheLeadsBiotech #MeganMcGill #BrenigTherapeutics #BiotechLeadership #WomenInBiotech #WomenInScience #LifeSciences

What does it really take to move from academia to industry… and then into the C-suite?

In this episode of She Leads Biotech, I sit down with Sailaja Battula, Chief Scientific Officer at Ankyra Therapeutics, whose journey is anything but conventional.

Born and raised on a farm in South India, Sailaja became the first in her family to attend college. She completed her PhD while raising two young children, applied for over 200 industry roles to make her transition, built immunology teams from scratch, and ultimately stepped into the CSO role at a pivotal moment for her company.

This is a conversation about intention, discipline, leadership growth, and knowing when you are ready, even before you fully believe it yourself.

We cover:
• Transitioning from academia to industry
• What hiring managers really look for
• Building and leading discovery teams
• Moving from VP to CSO
• Leadership vs management in scientific roles
• Raising a family while building a biotech career

If you are thinking about your next move, especially into leadership, this episode is packed with clarity and practical insight.

Chapters:

00:00 Introduction
01:40 Growing up on a farm in South India
07:01 Education, marriage, and moving to the US
08:48 Breaking into biotech with a newborn
11:19 PhD, postdoc, and moving into immuno-oncology
14:37 Why transitioning from academia to industry is hard
19:21 The three questions to ask before applying for a role
22:46 Career progression from scientist to VP
30:12 Stepping into the CSO role at Ankyra
36:16 What changes when you join the C-suite
38:10 Leadership vs management in science
40:38 Advice to her younger self
42:03 Using LinkedIn strategically for career growth
43:42 What’s next as CSO

🎙️ Subscribe for more conversations with women shaping the future of biotech.

#SheLeadsBiotech #SailajaBattula #AnkyraTherapeutics #ChiefScientificOfficer #BiotechLeadership #WomenInScience #CNAUSAExecutiveSearch

In this episode of She Leads Biotech, I sit down with Mori Mohseni, Head of Biology at VidaVinci, for a powerful conversation about persistence, purpose, and what it really takes to lead in drug discovery.

From her early fascination with biology to pivotal roles at AstraZeneca, Novartis, BMS, and now startup biotech, Mori’s career has been defined by one recurring theme: give her the hard problem.

We talk about what it means to search for truth in science, even when the answer isn’t what you hoped for. We explore the transition from big pharma to biotech to startup life, and why those moves were intentional. And we dive into leadership, team building, and the obsession required to move breakthrough science forward.

This is a conversation about loving the work enough to stay with it when it’s difficult, and inspiring others to do the same.

📌 Chapters / Timestamps

00:00 – Introduction and Mori’s early path into science

03:40 – Falling in love with biology and choosing research over medicine

08:10 – The leap from academia into industry

12:00 – A pivotal lesson: “Look for the truth” in drug discovery

15:20 – Seeing a drug go from bench to patient

18:45 – Big pharma vs biotech vs startup: what really changes

23:15 – Building infrastructure from scratch in smaller companies

27:30 – Leading as a servant leader and building strong teams

31:40 – Advice for young scientists navigating today’s market

35:50 – The future of biotech and the need for early innovation funding

40:10 – Leadership in biotech means loving what you do

Closing the Diagnostic Gap: Leadership, Equity, and Global Health with Devasena Gnanashanmugam

In this episode of She Leads Biotech, I sit down with Devasena Gnanashanmugam, VP of Medical Affairs at Cepheid, for a deeply thoughtful conversation about diagnostics, equity, and what it really means to lead in global healthcare.

Devasena’s journey spans medical training in India, pediatric infectious disease at Stanford, work at the NIH, and now industry leadership in molecular diagnostics. But at the center of it all is one consistent mission: improving access to timely, accurate diagnosis for the patients who need it most.

We talk about tuberculosis, HIV, COVID, and the persistent global diagnostic gap — and why identifying the problem correctly is often the most powerful intervention of all.

This episode is about science, yes. But it is also about humility, collaboration, and the responsibility that comes with leadership.

📌 Chapters / Timestamps

00:00 – Meet Devasena Gnanashanmugam
03:10 – From India to Stanford: early influences and medical training
07:45 – Why infectious disease and global health became her focus
11:20 – Tuberculosis as a medical and social justice issue
15:05 – “Find the bug so you can get the drug” – the power of diagnostics
18:40 – The global diagnostic gap and access challenges
22:15 – Lessons from COVID and what changed in molecular testing
26:30 – Transitioning from academia and NIH to industry
30:05 – The evolving role of physicians in biotech and diagnostics
33:50 – Leading from the front and from behind
37:10 – Collaboration, resilience, and staying grounded in purpose

🎙 Listen now on Spotify, YouTube, Apple Podcasts, or wherever you tune in.

#SheLeadsBiotech #DevasenaGnanashanmugam #Cepheid #GlobalHealth #Diagnostics #MedicalAffairs #WomenInSTEM #LifeSciencesLeadership #CNAUSAExecutiveSearch #SharronCoxStudio

In this episode of She Leads Biotech, host Sharron Cox speaks with Megan Forrest, Chief Operating Officer at Caring Cross, about a purpose-driven career shaped by science, family, and impact.

Megan shares how she navigated:

• Becoming a mother while completing her degrees

• Career shifts between biotech and nonprofit

• Leading a viral vector program through BLA approval

• Taking a full year off — and choosing to come back

• Why the mission of Caring Cross was the “perfect storm” opportunity

This is a compelling story of resilience, reinvention, and how the right role can align everything you've worked for.

🔗 Learn more about Caring Cross: https://caringcross.org

📌 Chapters:
00:00 – Meet Megan Forrest
02:15 – From science to motherhood: balancing ambition early
06:30 – Her early biotech roles and learning fast
09:45 – The leap into nonprofit and what it taught her
14:00 – Running a GMP viral vector program to BLA
17:25 – Walking away (and why)
21:10 – What drew her back to biotech
24:00 – How Caring Cross found her at the perfect time
27:30 – The COO role: building from experience
30:50 – Advice to women making unconventional career moves
33:45 – Rapid fire: role models, reading, and what’s next

🎙️ Listen now and hear how a life built on passion and adaptability led to a role with real global impact.

#SheLeadsBiotech #CaringCross #MeganForrest #BiotechLeadership #COO #CellTherapy #NonprofitBiotech #CareerComeback #CNAUSAExecutiveSearch #LifeSciencesLeadership

Kate Skrable didn’t plan on a career in biotech. But when med school doors didn’t open, she built a different path — one that’s led her to Pfizer, where she now serves as VP of Strategic Partnerships, leading global deals across multiple therapeutic areas.

In this episode of She Leads Biotech, Kate joins Sharron for a candid, funny, and deeply insightful conversation about owning your story, leading with purpose, and preparing for board service.

They talk about:

• What “fail forward” really means

• Growing up with grit and staying grounded in purpose

• Servant leadership and hiring A-players

• The power of Women in Bio’s Boardroom Ready program

• What smaller companies really need from a commercial advisor

🎙 Chapters / Timestamps
00:00 – Meet Kate Skrable
03:00 – Med school rejections and a new path into biotech
06:30 – Building resilience and finding purpose through pivots
10:45 – Why scarcity shaped her approach to leadership
14:20 – The power of servant leadership and hiring strong teams
17:35 – Making the leap into strategic partnerships at Pfizer
22:15 – Joining Women in Bio’s Boardroom Ready program
26:00 – What early-stage boards really need from commercial voices
30:00 – Advice to women: Don’t play small — say yes and figure it out later
33:10 – What’s next for Kate Skrable

Whether you’re navigating your own career pivot or building your board CV, this episode will leave you energized and empowered.

🎁 Follow for more episodes celebrating women in science, strategy, and leadership.
🎧 Listen on Spotify, Apple, or YouTube.

#SheLeadsBiotech | Hosted by Sharron Cox | CNA USA Executive Search

What happens when a heart surgeon gets fed up with “good enough”?

In this episode of She Leads Biotech, I sit down with Dr. Meghana Helder-Surgeon, practicing cardiac surgeon and Founder & CEO of Octin Health. She shares how one sleepless night in the OR — and one patient outcome she couldn’t let go of — led her to build a medtech company from her basement, starting with a garden hose, a drill, and a whole lot of determination.

We talk about:

• Being a woman in one of the most male-dominated specialties in medicine

• What it takes to spot a gap in care — and do something about it

• Why she didn’t wait for permission, funding, or perfect conditions to start

• How she balances leadership, clinical practice, motherhood, and mission

• What she wants every young woman in STEM to hear

💬 “You don’t have to change who you are to lead. You just have to stop apologizing for it.”

📌 Chapters / Timestamps

00:00 – Meet Meghana Helder and the origins of Octin Health
03:20 – What it’s like to be a woman in cardiac surgery (3% club)
06:45 – The patient case that changed everything
10:00 – Building her first prototype with a garden hose and grit
14:15 – Partnering with her husband and navigating startup life
17:30 – What she’s learned about leadership along the way
21:00 – Balancing motherhood, medicine, and entrepreneurship
25:00 – Advice for women who feel like they don’t “fit the mold”
28:00 – What’s next for Octin Health

🎧 Now streaming on Spotify, YouTube, Apple Podcasts & more

#SheLeadsBiotech #MeghanaHelder #OctinHealth #WomenInSTEM #MedTechFounders #CardiacSurgery #LifeSciencesLeadership #StartupJourney #AuthenticLeadership #CNAUSAExecutiveSearch #SharronCoxStudio

This week on She Leads Biotech, I’m joined by Stacy Lindborg, CEO and Board Director at IMUNON, whose career journey, from stats and data to the biotech C-suite, is a powerful example of purpose-driven leadership.

In this episode, Stacy shares how her training in statistics shaped her approach to decision-making, the personal values that guided her transition to CEO, and how IMUNON is advancing new therapies in ovarian cancer that could shift the standard of care.

She brings a rare blend of rigor, humility, and heart to the conversation and reminds us that leadership isn’t about ego. It’s about evidence, conviction, and the courage to follow both.

📌 Chapters / Timestamps00:00 – Meet Stacy Lindborg and her journey from statistics to biotech
03:45 – Early career lessons and the power of evidence-based decision-making
07:30 – Leading with curiosity, not ego
10:15 – Becoming CEO at IMUNON and what surprised her most
14:00 – IMUNON’s work in ovarian cancer and immune-gene therapy
17:20 – How personal loss and patient focus guide her leadership
21:40 – Mentorship, gender dynamics, and modeling what’s possible
26:00 – Why biotech needs both scientific clarity and emotional connection
30:30 – Final thoughts on staying grounded and building a legacy

🎙️ This episode is proudly presented by CNA USA Executive Search.

Listen now on Spotify, YouTube, Apple Podcasts, or wherever you get your favorite episodes.

#SheLeadsBiotech #StacyLindborg #IMUNON #WomenInSTEM #BiotechLeadership #OvarianCancer #LifeSciencesInnovation #AuthenticLeadership #SharronCox #CNAUSAExecutiveSearch #ExecutiveLeadership #PurposeDrivenCareers

Mentorship, Mid-Career Pivots & Women in STEM — with Brittany J. Bell

Description:
When Brittany J. Bell realized med school wasn’t her path, she didn’t give up on science—she found a new one.

In this episode of She Leads Biotech, Brittany joins host Sharron Cox to share how she turned her love of laboratory science into a purpose-driven career in commercial pharma. From lab bench to boardrooms, Brittany’s story is filled with pivots, mentorship, and a passion for supporting the next generation of women in STEM.

🎙️ We cover:

• What medical laboratory science actually is—and why it’s so vital

• Career pathways beyond the lab that most people don’t know about

• How two mentors gave Brittany the confidence to leap into industry

• Why young women need space to grow, not just directions

• The role of Women in Bio and how to get involved

• Resumes, AI, and what hiring managers should really be looking for

💡 Plus: Brittany’s take on leadership, mentorship, and the underrated power of following your gut.

A thoughtful, inspiring conversation for anyone navigating career uncertainty, mentoring others, or just trying to find their place in the ever-evolving world of life sciences.

Welcome to Season 4 of She Leads Biotech and we’re starting strong.

This week, host Sharron Cox is joined by Melissa and Amy Arthur, sisters and co-founders of the Arthur Leadership Group, who bring decades of experience coaching women in biotech, medtech, diagnostics, and STEM.

Their work focuses on helping women navigate burnout, build resilience, and lead with authenticity — not exhaustion.

In this episode:

• The Career Catalyst framework for creating clarity, confidence, and momentum

• Power partnerships: what they are, and how to build them

• Why women in STEM still struggle with overwork, perfectionism, and self-doubt

• The link between identity and leadership

• Tools for building a values-aligned career in 2026

  
  

🎁 Special Gifts for She Leads Biotech Listeners
From the Arthur Leadership Group:
✅ A downloadable Power Partnerships Activation Guide — a framework for sourcing the support you need to thrive in 2026
✅ A complimentary, confidential Career Catalyst Coaching Session — a private 1:1 session to gain clarity on your vision, activate practical steps, and tap into mindsets and networks that fuel momentum.

👉 Click here to claim your gifts

Learn more about Amy & Melissa’s work at: www.arthurleadershipgroup.com

#SheLeadsBiotech #ArthurLeadershipGroup #WomenInSTEM #CareerCatalyst #LeadershipCoaching #AuthenticLeadership #PowerPartnerships #CNAUSA #SharronCox

Terri Gaskell | CTO, Rinri Therapeutics
Restoring Hearing. Redefining Possibility.

In this episode, I speak with Terri Gaskell, Chief Technology Officer at Rinri Therapeutics, about the revolutionary work her team is doing to treat sensorineural hearing loss through stem cell therapy.

Terri shares her remarkable journey from academia to biotech, the real-world hurdles of early-stage leadership, and the power of staying grounded (even when things get weird, wild, or wonderfully promising).

We talk science, strategy, identity, and authenticity — all wrapped up in a clinical trial story that just might restore hearing for those who’ve lost it.

🎙️ This episode of She Leads Biotech is proudly sponsored by Phacilitate & Women in Advanced Therapies (WIAT).

📌 Chapters / Timestamps:

00:00 – Meet Terri Gaskell & the Rinri mission
03:05 – The science behind restoring hearing via stem cells
07:20 – From university spinout to clinical trials: how it all began
11:40 – Navigating burnout & building balanced leadership
14:30 – Why authenticity matters more than ever in biotech
17:25 – Terri’s Women in Advanced Therapies experience
19:40 – The highs, lows, and marigolds of team management
22:55 – How academia prepared (and didn’t prepare) her for biotech
26:15 – Advice for new biotech leaders: confidence vs competence
29:30 – Rinri’s clinical pipeline and what’s next
33:00 – Final reflections on purpose, progress, and patient impact

#SheLeadsBiotech #TerriGaskell #RinriTherapeutics #HearingLoss #CellTherapy #BiotechLeadership #WomenInSTEM #RegenerativeMedicine #CNAInternationalUSA #SharronCoxStudio #WIAT #Phacilitate #LifeSciences

Showing Up Fully: Katrina Rice on Leadership, Identity & Inclusive Trials
This week, I sit down with Katrina Rice, Chief Delivery Officer of Biometrics Services at eClinical Solutions, for a raw and empowering conversation about identity, leadership, and impact.

Katrina shares her journey from a first-gen college student in Alabama to a self-made C-level executive — and the courage it took to create the job she wanted when no one else offered it. We talk about the power of showing up as your full self, the ongoing challenges facing women of color in biosciences, and why diversity in clinical trials isn’t optional — it’s life-saving.

🎙️ Sponsored by Phacilitate & Women in Advanced Therapies (WIAT)

Whether you're mentoring others, navigating your own path, or working to make your workplace more inclusive, Katrina’s story is a masterclass in resilience and authenticity.

📌 Chapters / Timestamps

00:00 – Intro
02:15 – Growing up in Alabama and finding a path into science
05:45 – What it felt like to be the only Black woman in the room
08:30 – Transitioning from IT and government work to clinical research
11:10 – Creating her own role at eClinical Solutions
15:45 – What it means to lead with purpose, not just title
20:00 – Diversity in clinical trials: why it matters and where we’re falling short
25:30 – Representing communities of color in data and design
29:45 – Advice for young professionals entering the life sciences
34:00 – The power of authenticity and finding your own leadership style
37:10 – Closing thoughts: identity, impact, and legacy

Full episode now live on Spotify, YouTube, and wherever you get your podcasts.

#SheLeadsBiotech #Phacilitate #WIAT #KatrinaRice #eClinicalSolutions #DiversityInClinicalTrials #BiotechLeadership #WomenInSTEM #AuthenticLeadership #LifeSciences #SharronCoxStudio #CNAInternationalUSA

From Molecules to Machine Learning: CTO Chaemin Lim on Drug Design & Leadership.
What does drug discovery look like in the age of AI?

In this episode of She Leads Biotech, Sharron Cox sits down with Chaemin Lim, Chief Technology Officer of Coiled Therapeutics, for a wide-ranging discussion that spans synthetic chemistry, startup life, and the future of AI in oncology.

With over 15 years in drug development, Chaemin shares how her love of chemistry began in her father’s lab in Korea and evolved into a career at the intersection of data, design, and deep science. From building AI tools for medicinal chemists to learning how to translate science for investors, her journey is anything but linear and all the more inspiring for it.

In this episode:
00:00 Intro
02:30 Growing up in science (and her dad’s chemistry lab)
05:45 Pharmacy school and falling in love with drug development
10:40 Building her own computational chemistry lab in grad school
17:30 From postdoc to industry: how AI came into play
21:00 What AI can and can’t do in drug discovery
26:30 Startup life and translating science to strategy
29:00 Advice for women in biotech and defining yourself as a “designer”
33:00 What’s next for Coiled Therapeutics

Tune in for a thoughtful, practical, and occasionally hilarious conversation that proves science and leadership are anything but boring.

#SheLeadsBiotech #ChaeminLim #CoiledTherapeutics #DrugDesign #AIInBiotech #WomenInSTEM #AuthenticLeadership #LifeSciences #BiotechLeadership #CNAInternationalUSA

In this episode of She Leads Biotech, I sit down with Carolyn Yeago, Director of the MS in Biomedical Innovation & Development – Advanced Therapeutics at Emory University.

Carolyn’s career has taken her from being the first female co-op engineer at a med-tech company to shaping how the next generation of biotech leaders are trained — with a strong foundation in clinical, regulatory, and commercial strategy.

We talk about:

• Why early-stage biotech companies often skip critical operational knowledge

• How academia and industry can work together more effectively

• The importance of building teams who understand the why, not just the how

• What’s happening in Atlanta’s growing biotech ecosystem

• And how this new master’s program is filling the gaps most startups don’t even know they have

If you’re hiring early-career talent or thinking about where your next pipeline of leadership will come from — this episode is for you.

📌 Chapters / Timestamps

00:00 – Meet Carolyn Yeago
03:00 – From co-op engineer to biotech educator
06:30 – The gaps she saw in early-stage teams
09:30 – Building a program around the full product lifecycle
13:30 – Regulatory awareness in the classroom
17:00 – Collaborating with industry, founders, and faculty
21:00 – What makes a student stand out in biotech
24:00 – The rise of biotech in Atlanta
27:00 – Final advice for future leaders

🎓 Applications for the 2026 cohort are now open.

🟣 This episode is sponsored by Phacilitate and Women in Advanced Therapies (WIAT).

#SheLeadsBiotech #CarolynYeago #EmoryUniversity #AdvancedTherapeutics #BiotechEducation #WomenInSTEM #WorkforceDevelopment #AcademicInnovation #LifeSciences #CNAInternationalUSA

In this episode of She Leads Biotech, I’m joined by Deanna Angello, a seasoned commercial leader whose career spans some of the biggest names in healthcare: Pfizer, Kite Pharma, J&J, and Genentech.

But this isn’t just a highlight reel of commercial success. It’s a conversation about what happens when life interrupts the script — and how that moment can bring clarity, courage, and an entirely new sense of purpose.

We talk about:

• Navigating career grief after personal loss

• How Genentech prepared her for some of the most high-stakes commercial threats in biotech

• Why FDA approval is only the beginning — not the end — of access

• Building scalable systems that serve both patients and teams

• What she's looking for in her next chapter as a Chief Commercial Officer

If you're building something big — and looking for someone who’s done it all but still thinks like a builder — you’ll want to hear this one.

📌 Chapters / Timestamps

00:00 – Meet Deanna Angello
02:00 – From Pfizer to Genentech: early lessons and leadership
06:00 – Grief, clarity, and stepping off the treadmill
10:00 – Building commercial systems that last
14:00 – Patient access and the real work after FDA approval
18:30 – What she’s looking for in her next CCO role
23:00 – Advice for leaders ready to rethink their own path

#SheLeadsBiotech #DeannaAngello #BiotechLeadership #WomenInSTEM #ChiefCommercialOfficer #LifeSciences #PatientAccess #AuthenticLeadership #CareerPivot #CNAInternationalUSA

In this episode of She Leads Biotech, Sharron Cox sits down with Theresa Tribble, a dynamic entrepreneur and life sciences leader whose career has taken her from health policy and MBA halls to some of the most innovative companies in biotech.

Theresa has led strategy and growth at Everlywell, BigHat Biosciences, and Droplet Biosciences, and now she’s preparing to summit Mount Kilimanjaro as part of the 2026 Timmerman Traverse — raising $1M+ for early-career cancer researchers.

This conversation is honest, bold, and full of insight for anyone navigating their own career pivots or seeking purpose in the path less traveled.

We talk about:

• Why she’s drawn to companies that “should already exist”

• The difference between mentors and sponsors (and how to find both)

• What made Everlywell the riskiest — and most rewarding — move

• Leadership without a science background (and why it works)

• The climb of a lifetime for cancer research

• Her personal checklist for knowing when to say “yes” to an idea

  
  

📌 Chapters / Timestamps

00:00 – Meet Theresa Tribble
02:00 – Her unexpected path into life sciences
05:00 – Working at Everlywell: a bold career leap
08:30 – Finding purpose in patient proximity
11:00 – How she evaluates new ideas and career moves
14:30 – Mentorship vs sponsorship
18:00 – BigHat Biosciences and Droplet: different models, shared mission
22:00 – Career pivot tips for people outside the lab
25:00 – Timmerman Traverse: climbing Kilimanjaro for cancer research
30:00 – Advice for building a career with meaning

🎧 Tune in for a conversation that blends strategy, mission, and a whole lot of heart.

In this episode of She Leads Biotech, Sharron Cox sits down with Katja Betts, CEO of PROGEN, one of Germany’s first biotech companies — now 40 years strong and still evolving.

Katja’s leadership journey is anything but typical. From marketing to the boardroom, she now leads a 45-person team that partners globally with biotech giants like Thermo Fisher and Bio-Techne. But at the heart of it all? A deep commitment to precision, collaboration, and progress that lasts.

They talk about:

• PROGEN’s mission to make gene therapy tools more accessible and scalable

• The leadership mindset Katja brought from brand strategy to biotech

• Why innovation doesn’t have to be loud to be bold

• Gender and generational bias in biotech leadership

• How PROGEN is supporting clients around the world — without losing focus

Whether you’re scaling a biotech company or building a career in life sciences, this episode offers a thoughtful, grounded take on leadership, growth, and impact.

📌 Timestamps / Chapters
00:00 – Meet Katja Betts & PROGEN’s history
03:30 – From branding to biotech: Katja’s unconventional career path
06:00 – What makes PROGEN different (and why clients stay 20+ years)
09:00 – The mission: Making gene therapy better, together
12:30 – Building tools that work without specialist equipment
15:00 – Collaborating with Thermo Fisher, Bio-Techne, and more
18:00 – Leadership in Germany: differences, networks, and gender dynamics
22:00 – The weight of legacy and the power of steady progress
25:00 – Advice for new leaders in biotech

🎧 Listen now and share with someone building something with meaning.

Jennifer Chain | The Leukopak Lady – Why Starting Materials Matter More Than You Think

In this episode of She Leads Biotech, host Sharron Cox sits down with Jennifer Chain, immunologist, consultant, and founder of CSM Consulting, to explore a topic most people in biotech overlook, the strategic importance of starting materials in cell and gene therapy.

Known on LinkedIn as The Leukopak Lady, Jennifer shares her journey from academia to entrepreneurship, her deep expertise in donor qualification, and why collection centers and therapy developers need to start thinking upstream if they want downstream success.

Chapters:
00:00 – Meet Jennifer Chain: From West Texas to starting materials expert
03:00 – Why she chose gamma delta T cells over cancer research
06:30 – Why donor selection is critical to manufacturing and clinical outcomes
10:30 – What most execs misunderstand about leukopaks
13:00 – How she built a consulting business (and the startup that didn’t work out)
17:00 – The viral video series: “The Leukopak Lady” on LinkedIn & YouTube
20:00 – The regulatory grey zones no one is talking about
23:00 – Centralized vs decentralized manufacturing: hidden bottlenecks
27:00 – Why donor stewardship is the new frontier in cell therapy
30:00 – Her advice for early-career scientists breaking into the space

Whether you're in CMC, clinical, regulatory, or BD — this episode will shift how you think about supply chains, success rates, and what it really means to build therapies that work.

Listen now and follow Jennifer at #LeukopakLady for more insight.

Susan Nichols has spent her career bridging the gap between innovation and impact. Now, as CEO of Propel Biosciences, she’s helping startups in the cell and gene therapy space build commercial strategies that work, for patients, investors, and everyone in between.

In this episode of #SheLeadsBiotech, Susan shares how her personal connection to rare disease shaped her path, what she learned transitioning from Big Pharma to biotech, and why commercialization isn’t just about revenue, it’s about responsibility.

Chapters:
00:00 – Meet Susan Nichols and her personal connection to rare disease
03:00 – Why cell and gene therapy felt like “sci-fi” — and what made her believe
06:30 – From Big Pharma to startup life: learning to lead without the handbook
10:00 – The patient as north star: what keeps her going
12:00 – Leadership vs. management: how her style evolved
17:00 – Managing individuals, not job titles
20:00 – Why mentoring isn’t about advice — it’s about curiosity
22:30 – What Propel Biosciences does, and how she helps companies get market-ready
26:00 – Why good science isn’t enough without a clear commercial pathway
30:00 – Breaking through the noise: messaging, clarity, and value
33:00 – Advice for those entering CGT (and what not to do)

🎧 Tune in to hear from a powerhouse who’s seen every side of the industry — and is now paying it forward.

In this episode of She Leads Biotech, Sharron Cox sits down with Angela Vollstedt, Director of Global Cell & Gene Therapies Portfolio at Novartis, for a conversation that blends operational grit with visionary thinking.

Angela’s career spans two decades in pharma — from legacy manufacturing to advanced therapies — and she’s now at the forefront of shaping how personalized medicine can become scalable, accessible, and sustainable.

We talk about:

• Her unexpected start in a male-dominated manufacturing environment

• The creative shift from operations to product development

• Rethinking biotech leadership in uncharted territory

• The “bus” model that could transform patient access in CGT

• The mindset young biotech professionals need to succeed today

Whether you’re scaling a CGT company or just starting out in life sciences, Angela’s story offers grounded insights and bold ideas about what it means to lead at the edge of innovation.

Listen now and share with a leader navigating the new frontier of biotech.

📌 Chapters / Timestamps:
00:00 – Meet Angela Vollstedt
01:00 – Her entry into pharma & manufacturing
05:00 – Being one of the only women in the room
07:00 – Lessons that shaped her leadership style
11:00 – Transitioning into product development
14:00 – Entering advanced therapies
16:00 – Balancing excellence with innovation
18:00 – A "bus" that could change patient access
23:00 – Why patient awareness matters
26:00 – What keeps her passionate about the work
28:00 – Advice for the next generation of biotech leaders

In this episode of She Leads Biotech, I sit down with Jeanne Hecht, CEO & Chairwoman of Lexitas Pharma Services, whose career spans global operations, clinical development, and private equity-backed growth — but whose leadership style is anything but cold and corporate.

Jeanne gets real about the lessons she learned the hard way: the dangers of micromanagement, the beauty of asking for help, and why ego has no place in building something that lasts.

We talk about:
🔹 Her early career in clinical research and how she learned to “speak investor”
🔹 Transitioning from doer to delegator — and how trust transformed her leadership
🔹 The role of PE firms in shaping biotech strategy
🔹 Her take on when founders should step back and bring in an operator
🔹 What it means to lead with humility and consistency — especially as a woman in the C-suite

💬 “A position of strength is when somebody understands they’re not in the right role — and they step aside so someone else can do it better.”

📌 Chapters / Timestamps
00:00 – Meet Jeanne Hecht
02:30 – From clinical trials to the business side of biotech
05:30 – The evolution of her leadership style: from micromanagement to mentorship
08:45 – How her team helps her lead better
11:00 – Building Lexitas with a people-first culture
14:00 – What investors are really looking for in leadership
17:00 – Advice for scientist-founders: when to step aside
20:00 – Gender, confidence, and owning the room
23:30 – Winning “CEO of the Year” on a chaotic morning
27:00 – The biggest lesson she’s still learning
30:00 – Her advice to women moving into executive roles

🎧 A must-listen for biotech leaders at every stage — grounded, generous, and refreshingly real.

#SheLeadsBiotech #JeanneHecht #LexitasPharma #WomenInLeadership #ClinicalDevelopment #PrivateEquity #BiotechLeadership #LifeSciences #CNAInternationalUSA

In this episode of She Leads Biotech, Sharron Cox sits down with Mini Manchanda, Senior Director of Precision Medicine at Kura Oncology, to explore a career built on curiosity, compassion, and bold pivots.

From her early research days in India to global biotech roles at Thermo Fisher, AstraZeneca, and now Kura, Mini shares how she’s helped shape the future of healthcare — one personalized solution at a time.

We talk about:
🔹 Redefining success after an early “failure”
🔹 Working across diagnostics, drug development, and precision medicine
🔹 Leading with intention in a high-growth biotech
🔹 The difference between precision medicine and precision health
🔹 Holistic care, Eastern medicine, and integrating new paradigms
🔹 Mentorship, identity, and finding meaning beyond your job title

“You don’t need to be hard to lead. You can lead with softness.”

An honest and uplifting conversation with a scientist, strategist, and leader who’s building better systems — and lifting others as she rises.

📌 Chapters / Timestamps
00:00 – Meet Mini Manchanda
02:00 – Childhood curiosity and falling in love with biology
06:00 – When medical school didn’t work out — and why that was okay
08:00 – The impact of constant relocation on resilience and adaptability
10:00 – Getting into research and moving abroad for grad school
12:00 – Transitioning from academia to industry
14:00 – Thermo Fisher, Saudi genome projects, and diagnostics development
16:00 – AstraZeneca and the global evolution of precision medicine
19:00 – The power of purpose-driven leadership
22:00 – What is precision medicine — and how is it evolving?
24:00 – The future of precision health and data-informed wellness
27:00 – Eastern vs. Western medicine: challenges and opportunities
32:00 – Identity, purpose, and career ambitions
34:00 – Advice for young women in science
36:00 – Mentorship and paying it forward

🎧 Listen now — and get inspired by a leader redefining what it means to do meaningful work in science and health.

#SheLeadsBiotech #MiniManchanda #KuraOncology #PrecisionMedicine #WomenInSTEM #AuthenticLeadership #LifeSciences #BiotechInnovation #CareerGrowth #HolisticHealthcare

In this episode of She Leads Biotech, I sit down with Rhonda Wallen, Founder & CEO of IleraBio, and a biotech leader whose career spans science, venture capital, entrepreneurship, and health equity.

Rhonda has built and advised companies from every angle, lab bench, boardroom, and investor pitch, and now she’s applying that experience to transform how we treat serious diseases through drug repurposing.

We talk about:
🔹 Her path from science to finance to founding
🔹 What it was like launching her first startup during the 2008 downturn
🔹 Lessons learned from rejection, reinvention, and raising capital
🔹 The mission behind IleraBio: affordable, repurposed therapies for underserved diseases
🔹 Her perspective on leadership, equity, and building with integrity

“There’s more than one way to build a successful biotech company. We just need investors who are willing to see it.”

📌 Chapters / Timestamps:
00:00 – Meet Rhonda Wallen and her journey into biotech
03:00 – From the lab to Wall Street: navigating early career pivots
06:30 – Founding her first company and learning the hard way
10:00 – Resilience, rejection, and raising capital as a woman in biotech
14:00 – The birth of IleraBio and why drug repurposing matters
18:30 – Funding models, access, and system change
22:00 – Boardrooms, balance, and redefining leadership
26:00 – Advice to founders navigating uncertainty
29:00 – What’s next for Rhonda and IleraBio

This episode is a masterclass in perseverance, perspective, and purpose, from a founder who’s seen biotech from every side and is reshaping it from within.

#SheLeadsBiotech #RhondaWallen #IleraBio #BiotechLeadership #WomenInSTEM #HealthEquity #DrugRepurposing #StartupFounder #AuthenticLeadership #LifeSciences #CNAInternationalUSA

In this episode of She Leads Biotech, I’m joined by Kristen Mittal, Co-founder & CEO of Mittal Consulting, a firm that’s quietly become one of the go-to regulatory partners for early-stage medtech startups across the U.S.

Kristen’s background as a biomedical engineer, combined with her deep understanding of regulatory and commercialization strategy, gives her a unique lens into what founders really need, especially in today’s tighter funding and approval climate.

We talk about:
🔹 How she built Mittal Consulting from a solo operation to a 20+ person team
🔹 Why most founders overlook regulatory until it’s too late
🔹 Her philosophy on aligning regulatory pathways with reimbursement strategy
🔹 The surprising truth about working with your spouse — and how they grew the business together
🔹 Her work with MedTech Women and why more women need to be in boardrooms

“If your product is regulatory-ready but not commercially viable, that’s not a win. Founders need better guidance earlier.”

📌 Chapters / Timestamps:
00:00 – Meet Kristen and the origin of Mittal Consulting
03:15 – The evolution from engineer to regulatory strategist
06:30 – Common mistakes founders make in FDA planning
10:00 – When to bring in regulatory expertise (spoiler: it’s early)
13:30 – Building a company with your husband (and staying sane)
16:00 – Hiring, culture, and growing during the pandemic
20:00 – Why FDA approval isn’t the final hurdle — reimbursement is
23:00 – MedTech Women, visibility, and equity in board leadership
26:00 – Advice to early-stage founders and regulatory professionals

Tune in to hear how Kristen is helping the next wave of medtech innovators build smart, from day one.

#SheLeadsBiotech #KristenMittal #MittalConsulting #MedTech #RegulatoryStrategy #WomenInSTEM #BoardRepresentation #Startups #BiotechLeadership #CNAInternationalUSA

In this episode of She Leads Biotech, CEO Sharron Cox speaks with Paula Soteropoulos, a biotech leader whose career spans Genzyme, Moderna, and founding and leading Akcea Therapeutics from inception to IPO.

With deep experience in rare diseases, drug development, commercialization, and board leadership, Paula reflects on how she built a career defined by curiosity, impact, and authentic leadership, and why she's now focused on bringing forward more accessible therapies for patients globally.

Topics include:
🔹 Her early days designing bioreactors and joining Genzyme during its most mission-driven era
🔹 Taking Akcea public and launching two rare disease drugs across multiple countries
🔹 How she scaled leadership teams, mentored the next generation, and made room for others to succeed
🔹 Why she’s now investing time and energy in women’s health and accessibility in gene therapy
🔹 The power of mentorship, board roles, and leading with purpose — not just performance

📌 Chapters / Timestamps
00:00 – From liberal arts to biotech: how Paula found the field
02:00 – Joining Genzyme and discovering her leadership potential
05:30 – Building Akcea: from spinout to IPO to drug launch
08:30 – Fundraising and operational challenges in today’s market
11:00 – Mentorship, sponsorship, and creating space for women
14:00 – Serving on boards and the value of diverse leadership experiences
18:00 – Building support systems and balancing family with career
22:00 – Her current work with 5AM Ventures and Ensoma
26:00 – Making gene therapy more accessible
30:00 – On leadership, authenticity, and the importance of sharing your “why”

This episode is packed with practical insights for biotech leaders at every stage, from first-time founders to seasoned executives navigating new chapters.

#SheLeadsBiotech #CNAInternationalUSA #PaulaSoteropoulos #BiotechLeadership #RareDiseases #GeneTherapy #WomenInSTEM #MentorshipMatters #AuthenticLeadership #LifeSciences #DrugDevelopment #BoardLeadership #VenturePartners #Akcea #Ensoma

In this episode of She Leads Biotech, host Sharron Cox, CEO of CNA International USA, speaks with Barbara Commisso, Business Development Manager at Evidenze, about building a biotech career from the ground up and why non-linear paths often lead to the most rewarding roles.

Barbara’s journey began with academic research in Germany and evolved through unexpected pivots, including a role as a study coordinator in a psychiatric unit in Italy, before she found her niche in clinical trials and business development. Today, she works remotely across global markets, helping to connect science, operations, and strategy in the evolving world of clinical research.

Topics include:
🔹 How she transitioned from academic neuroscience into clinical operations
🔹 The role of courage, self-belief, and mentorship in early-career pivots
🔹 Navigating remote work and the European biotech landscape
🔹 The rise of AI in clinical trials and how it’s shaping future roles
🔹 Why she now mentors PhDs and postdocs navigating the same uncertainty she once faced

📌 Chapters / Timestamps
00:00 – Meet Barbara and her early research career in Germany
03:00 – Returning to Italy and starting from scratch in clinical trials
06:00 – Moving into business development and working remotely
08:30 – Cultural contrasts in biotech across Europe
11:00 – How AI is reshaping clinical operations and trial design
14:00 – Funding, hiring, and market trends in life sciences
17:30 – The importance of mentorship and sharing your journey
20:00 – Advice to scientists looking to pivot into biotech
22:00 – What’s next for Barbara and the future of clinical research

A relatable and honest conversation about starting over, staying curious, and finding your place in biotech, even when the path isn’t linear.

#SheLeadsBiotech #CNAInternationalUSA #BarbaraCommisso #ClinicalResearch #CareerTransition #WomenInSTEM #LifeSciences #MentorshipMatters #BiotechLeadership #RemoteWork #AuthenticLeadership

In this episode of She Leads Biotech, I’m joined by Ami Mehr, COO & Digital Health Leader, who brings decades of experience in biotech, clinical trials, and digital health , and one of the most powerful personal stories I’ve heard.

Ami has led global teams, built startups, launched digital platforms, and advised major pharma, but she’s also a three-time cancer survivor. Her perspective on leadership is shaped not just by boardrooms and product launches, but by what it means to be on the other side of the healthcare system.

We talk about:
🔹 How to scale biotech operations and still stay human
🔹 The reality of being a woman in leadership and still underrepresented at the board level
🔹 Her advice for navigating career transitions, including when the path is unclear
🔹 The importance of storytelling, branding, and mentorship for senior women
🔹 And why being “comfortable with the uncomfortable” might be the most powerful career strategy of all

📌 Chapters / Timestamps
00:00 – Meet Ami Mehr and her path from software to life sciences
02:00 – Taking the leap into startups and regulatory leadership
04:00 – Lessons from scaling teams and building infrastructure
06:00 – The importance of mentorship (and being your own advocate)
08:30 – Her cancer journey and how it changed her view of the industry
12:00 – The gap between patient-centric messaging and real impact
15:00 – Career transitions, reinvention, and being honest about burnout
18:00 – Personal brand, storytelling, and visibility on LinkedIn
22:00 – Why the next move doesn’t always have to be “up”
25:00 – Final thoughts on leadership, courage, and purpose

This one’s a mix of strategy, reflection, and real talk, from a leader who’s seen the system from every angle and still shows up with clarity, heart, and conviction.

#SheLeadsBiotech #AmiMehr #WomenInSTEM #BiotechLeadership #PatientAdvocacy #CareerGrowth #DigitalHealth #AuthenticLeadership #LifeSciences #CNAInternationalUSA

In this episode of She Leads Biotech, I’m joined by Kristien Van Vlasselaer, VP of Operations at Gordian Biotechnology, a neuroscientist turned biotech exec, and someone who brings heart, systems thinking, and radical honesty to the leadership table.

Kristien shares how her journey through academia, consulting, and startups was shaped by personal challenges, neurodiversity, and a refusal to settle for environments that didn’t fit.

We dive into:
🔹 Making the leap from PhD to business roles
🔹 Her experience with late-diagnosed ADHD and how it reshaped her view of success
🔹 Why we need to stop calling them “soft skills”
🔹 The challenges of leadership as a woman and a mother in biotech
🔹 What it means to build healthy, human-centered teams in fast-paced environments

This is one of those conversations that stays with you, equal parts strategy, vulnerability, and real talk.

📌 Chapters / Timestamps
00:00 – Meet Kristien and her career path from neuroscience to biotech
03:00 – Consulting at BCG and the reality of burnout
06:45 – Getting diagnosed with ADHD and what changed
10:30 – Navigating imposter syndrome and perfectionism
13:00 – Leaving toxic environments and finding career clarity
16:45 – Building better teams: why leadership starts with empathy
19:30 – Why scientists need training beyond the technical
22:00 – Breaking the myth of “soft” skills
25:00 – Parenting, identity, and embracing non-linear careers
28:30 – Advice to early-career scientists: say yes, then figure it out
30:00 – What she’s building now at Gordian and why it matters

🎧 Tune in for an honest and empowering conversation with someone who’s redefining leadership on her own terms.

#SheLeadsBiotech #KristienVanVlasselaer #GordianBiotechnology #WomenInSTEM #ADHDLeadership #BiotechOperations #AuthenticLeadership #NeurodivergentVoices #LifeSciences #CNAInternationalUSA

In this episode of She Leads Biotech, I sit down with Georgie Kovacs — founder of Fempower Health and a powerhouse in the women’s health space to talk about fertility, diagnostics, and why solving for passion isn’t enough.

Georgie spent years in commercial leadership roles at top biopharma companies before launching a women’s health startup inspired by her own struggle with unexplained infertility. When the business model proved tough to sustain, she turned her research into one of the most respected podcasts in the field and now consults with startups, investors, and accelerators shaping the next era of women’s health innovation.

We talk about:
🔹 Her early career in sales and marketing at BMS
🔹 The fertility journey that changed her path
🔹 Why women's health startups need more than a good idea — they need business discipline
🔹 What delays endometriosis diagnoses and how we fix it
🔹 Building tools to help women navigate a fragmented healthcare system
🔹 Why prevention is the future but it still needs funding
🔹 Real innovations (like smarter bassinets and hormone-linked mental health tech) that give her hope

📌 Chapters / Timestamps
00:00 – Meet Georgie and her pharma journey
03:00 – From fertility struggles to founding a startup
07:00 – Building vs. launching: the harsh reality of business models in women’s health
10:00 – From idea to podcast: launching Fempower Health
13:00 – Endometriosis, delayed diagnoses, and missing data
16:00 – Coaching women through the healthcare maze
18:00 – Why femtech needs to speak the language of investors
21:00 – Examples of innovation in maternal health, sexual wellness, and hormone care
25:00 – What Georgie’s learned advising startups and accelerators
28:00 – Her advice for women entering the space: passion isn’t enough

Tune in for an honest, strategic, and inspiring look at what it really takes to move women’s health forward.

In this episode of She Leads Biotech, I’m joined by Denise Dajles, President & CEO at Cytrellis Biosystems, Inc. who has built her career at the dynamic intersection of engineering, medical devices, and executive leadership.

Denise’s story starts with curiosity in Costa Rica and takes us through academia, entrepreneurship, and boardrooms across the US. She shares how being “naively fearless” helped her navigate male-dominated spaces, why saying yes before you feel ready can change your life, and how she’s now leading Cytrellis Biosystems, Inc. through a major relaunch and cultural transformation.

We talk about:
🔹 How she discovered her passion for engineering and medical devices
🔹 Moving from operations and R&D to the C-suite
🔹 The underestimated power of mentors (and why most of hers were men)
🔹 Balancing family, ambition, and identity and letting go of perfection
🔹 Why authenticity is non-negotiable in her leadership style
🔹 Her vision for Cytrellis: expanding from aesthetics to therapeutic and global applications

📌 Chapters / Timestamps
00:00 – Meet Denise and her journey from Costa Rica to the US
03:00 – Early career in medical device manufacturing
06:00 – Starting (and selling) her first company
09:00 – Moving back into academia and building programs for women in STEM
12:00 – Returning to industry and finding her voice in leadership
15:00 – Mentorship, femtorship, and creating space for other women
18:00 – Leading Cytrellis: restructuring, culture, and future growth
22:00 – The power of saying yes and preparing later
25:00 – Embracing authenticity and setting your own limits
28:00 – Cytrellis technology: aesthetics, scars, and beyond

🎧 Tune in to hear Denise’s refreshingly real take on leadership, risk-taking, and building a career that’s true to you.

#SheLeadsBiotech #DeniseDajles #Cytrellis #WomenInSTEM #BiotechLeadership #AuthenticLeadership #EngineeringLeadership #Femtorship #SayYes #CareerGrowth #CNAInternationalUSA

In this episode of She Leads Biotech, I sit down with Maria Haugen, founder of Foxx Health a new app designed to help women take control of their health journey and walk into appointments prepared, confident, and heard.

Maria’s story began when she experienced terrifying heart symptoms and felt dismissed and misdiagnosed for months. Out of that frustration, she decided to build what she wished she’d had: a health companion app that guides you through questions, tracks symptoms, and helps you advocate for yourself in the exam room.

We talk about:
🔹 How her personal health scare sparked a new mission

🔹 Why women are diagnosed later and feel dismissed more often
🔹 The reality of data privacy and building an app during a challenging time for women’s health in the U.S.
🔹 Creating checklists, tracking tools, and community connections all in one platform

🔹 The future of FoXX Health from global expansion to partnering with doctors

📌 Chapters / Timestamps
00:00 – Meet Maria and her journey from marketing to health tech
02:00 – A heart scare that changed everything
04:30 – Why women feel dismissed (and the shocking stats)
06:30 – How FoXX Health empowers women before appointments
09:00 – Privacy, safety, and state-by-state considerations
12:00 – The app’s features: checklists, trackers, and community support
16:00 – Building partnerships and launching globally
18:00 – Future vision: data visualization and empowering providers
22:00 – Why it’s about support, not blame

🎧 Listen now to learn how one woman turned a personal struggle into a tool to help thousands find their voice in healthcare.

#SheLeadsBiotech #FoXXHealth #WomenInHealth #PatientAdvocacy #DigitalHealth #EmpoweredPatients #WomenInSTEM #HealthTechInnovation #CNAInternationalUSA